These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15027881)

  • 21. Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor.
    Bloms-Funke P; Gillen C; Schuettler AJ; Wnendt S
    Peptides; 2000 Jul; 21(7):1141-6. PubMed ID: 10998549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species differences in the efficacy of compounds at the nociceptin receptor (ORL1).
    Burnside JL; Rodriguez L; Toll L
    Peptides; 2000 Jul; 21(7):1147-54. PubMed ID: 10998550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity studies on high affinity NOP-active hexapeptides.
    Judd AK; Tuttle DJ; Jones RW; Sanchez A; Polgar W; Berzetei-Gurske I; Toll L
    J Pept Res; 2004 Sep; 64(3):87-94. PubMed ID: 15317498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors.
    Zaveri N; Polgar WE; Olsen CM; Kelson AB; Grundt P; Lewis JW; Toll L
    Eur J Pharmacol; 2001 Sep; 428(1):29-36. PubMed ID: 11779034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G; Rizzi A; Guerrini R; Barnes TA; McDonald J; Hebbes CP; Mela F; Kenigs VA; Marzola G; Rizzi D; Gavioli E; Zucchini S; Regoli D; Morari M; Salvadori S; Rowbotham DJ; Lambert DG; Kapusta DR; Calo' G
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1114-23. PubMed ID: 15509719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung.
    Corboz MR; Rivelli MA; Egan RW; Tulshian D; Matasi J; Fawzi AB; Benbow L; Smith-Torhan A; Zhang H; Hey JA
    Eur J Pharmacol; 2000 Aug; 402(1-2):171-9. PubMed ID: 10940371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.
    Neal CR; Owens CE; Taylor LP; Hoversten MT; Akil H; Watson SJ
    J Chem Neuroanat; 2003 Jul; 25(4):233-47. PubMed ID: 12842269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
    Mason SL; Ho M; Nicholson J; McKnight AT
    Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonist.
    Li J; Isozaki K; Okada K; Matsushima A; Nose T; Costa T; Shimohigashi Y
    Bioorg Med Chem; 2008 Mar; 16(5):2635-44. PubMed ID: 18068993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
    Hawkinson JE; Acosta-Burruel M; Espitia SA
    Eur J Pharmacol; 2000 Feb; 389(2-3):107-14. PubMed ID: 10688973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor binding properties and antinociceptive effects of chimeric peptides consisting of a micro-opioid receptor agonist and an ORL1 receptor antagonist.
    Kawano S; Ito R; Nishiyama M; Kubo M; Matsushima T; Minamisawa M; Ambo A; Sasaki Y
    Biol Pharm Bull; 2007 Jul; 30(7):1260-4. PubMed ID: 17603164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.
    McDonald J; Barnes TA; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
    Eur J Pharmacol; 2002 May; 443(1-3):7-12. PubMed ID: 12044785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B; Carrà G; Fantin M; Fischetti C; Hebbes C; McDonald J; Barnes TA; Rizzi A; Trapella C; Fanton G; Morari M; Lambert DG; Regoli D; Calò G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):961-7. PubMed ID: 17329552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.
    Huang P; Kehner GB; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2001 May; 297(2):688-95. PubMed ID: 11303059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of rat olfactory bulb.
    Onali P; Olianas MC
    Br J Pharmacol; 2004 Nov; 143(5):638-48. PubMed ID: 15451772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tritium-labelled isovaleryl-RYYRIK-NH2 as potential antagonist probe for ORL1 nociceptin receptor.
    Inamine S; Nishimura H; Li J; Isozaki K; Matsushima A; Costa T; Shimohigashi Y
    Bioorg Med Chem; 2014 Nov; 22(21):5902-9. PubMed ID: 25284251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phe1phi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells.
    Olianas MC; Maullu C; Ingianni A; Onali P
    Neuroreport; 1999 Apr; 10(5):1127-31. PubMed ID: 10321496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.
    Berger H; Bigoni R; Albrecht E; Richter RM; Krause E; Bienert M; Calo' G
    Peptides; 2000 Jul; 21(7):1131-9. PubMed ID: 10998548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
    Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
    J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.